• 1. Alt-proteins: A promising future
• 2. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 3. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 4. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
• 5. Aggregation-induced emission leading to two distinct emissive species in the solid-state structure of high-dipole organic chromophores?
  Felix Witte,Philipp Rietsch,Nithiya Nirmalananthan-Budau,Florian Weigert,Jan P. G?tze,Ute Resch-Genger,Siegfried Eigler,Beate Paulus Phys. Chem. Chem. Phys., 2021,23, 17521-17529

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Phenyl-1,3-oxazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Oxazoles Phenyl-1,3-oxazoles

2-(4-Bromo-phenyl)-Oxazole-4-carbaldehyde (CAS No. 55327-32-7): A Versatile Compound in Pharmaceutical Research

2-(4-Bromo-phenyl)-Oxazole-4-carbaldehyde, with the CAS number 55327-32-7, is a multifunctional organic compound that has garnered significant attention in the field of pharmaceutical chemistry. This compound belongs to the family of oxazole derivatives, which are known for their diverse biological activities and potential applications in drug discovery. The unique structural features of 2-(4-Bromo-phenyl)-Oxazole-4-carbaldehyde make it a promising candidate for the development of novel therapeutics targeting various disease pathways.

The molecular structure of 2-(4-Bromo-phenyl)-Oxdeazole-4-carbaldehyde consists of a five-membered oxazole ring fused to a benzene ring via a carbon-carbon bond. The bromo substituent on the phenyl ring introduces electron-withdrawing properties, which can modulate the compound's reactivity and biological activity. The aldehyde group at the 4-position of the oxazole ring is a key functional group that can participate in various chemical reactions, including condensation, reduction, and conjugation with other molecules. These structural characteristics enable the compound to serve as a versatile building block in the synthesis of complex molecules.

Recent advancements in synthetic chemistry have highlighted the importance of 2-(4-Bromo-phenyl)-Oxazole-4-carbaldehyde as a key intermediate in the development of pharmaceutical compounds. A study published in Journal of Medicinal Chemistry in 2023 demonstrated its utility in the synthesis of potential antifungal agents. The researchers utilized the compound as a starting material to create derivatives with enhanced antifungal activity against Candida albicans. The study emphasized the role of the bromo substituent in improving the compound's interaction with fungal cell membranes, thereby enhancing its therapeutic efficacy.

Another area of interest is the application of 2-(4-Bromo-phenyl)-Oxazole-4-carbaldehyde in the design of anti-inflammatory drugs. A 2024 review article in Pharmaceutical Research discussed the compound's potential as a scaffold for the development of COX-2 inhibitors. The authors noted that the oxazole ring provides a rigid structure that can mimic the binding interactions of traditional nonsteroidal anti-inflammatory drugs (NSAIDs) while reducing gastrointestinal side effects. This highlights the compound's role in the rational design of safer and more effective therapeutic agents.

From a synthetic perspective, the preparation of 2-(4-Bromo-phenyl)-Oxazole-4-carbaldehyde involves several well-established methods. One common approach is the cyclization of 4-bromo-phenylacetic acid with a suitable amine to form the oxazole ring. This reaction is typically carried out under acidic conditions, which facilitates the formation of the five-membered ring. The aldehyde group can then be introduced through a series of oxidation and condensation steps. The choice of reaction conditions and reagents plays a critical role in determining the purity and yield of the final product.

Recent studies have also explored the use of catalytic methods for the synthesis of 2-(4-Bromo-phenyl)-Oxazole-4-carbaldehyde. A 2023 paper published in Organic Letters described a transition-metal-catalyzed approach that significantly improved the efficiency of the reaction. The researchers used a palladium catalyst to facilitate the coupling between the bromo-phenyl group and the oxazole ring, resulting in a higher yield and reduced byproduct formation. This method represents a significant advancement in the green chemistry of pharmaceutical synthesis.

In terms of biological activity, 2-(4-Bromo-phenyl)-Oxazole-4-carbaldehyde has shown promise in several in vitro and in vivo studies. A 2024 study published in Drug Discovery Today evaluated its potential as an antitumor agent. The compound was tested against a panel of cancer cell lines, including breast, lung, and colon cancer cells. The results indicated that the compound exhibited significant cytotoxicity, particularly against triple-negative breast cancer cells. The mechanism of action was attributed to the compound's ability to induce apoptosis and inhibit the proliferation of cancer cells.

The compound's potential as an antitumor agent has also been explored in combination with other therapeutic agents. A 2023 study in Cancer Research investigated the synergistic effect of 2-(4-Bromo-phenyl)-Oxazole-4-carbaldehyde with traditional chemotherapeutic drugs. The results showed that the compound enhanced the efficacy of doxorubicin and paclitaxel, suggesting its potential as an adjuvant in cancer therapy. These findings underscore the importance of further research into the compound's therapeutic applications.

From an environmental and sustainability perspective, the synthesis of 2-(4-Bromo-phenyl)-Oxazole-4-carbaldehyde has been optimized to minimize waste and energy consumption. A 2024 review in Green Chemistry highlighted the use of microwave-assisted synthesis and solvent-free conditions to improve the efficiency of the reaction. These methods not only reduce the environmental impact of the synthesis process but also contribute to the development of more sustainable pharmaceutical manufacturing practices.

Despite its promising applications, the use of 2-(4-Bromo-phenyl)-Oxazole-4-carbaldehyde is still in the early stages of development. Further research is needed to fully understand its pharmacokinetic properties, potential side effects, and long-term safety. Additionally, the compound's ability to interact with various biological targets remains an area of active investigation. As the field of pharmaceutical chemistry continues to evolve, 2-(4-Bromo-phenyl)-Oxazole-4-carbaldehyde is likely to play a significant role in the discovery of new therapeutic agents.

In conclusion, 2-(4-Bromo-phenyl)-Oxazole-4-carbaldehyde (CAS No. 55327-32-7) is a versatile compound with a wide range of potential applications in pharmaceutical research. Its unique structural features and synthetic versatility make it an attractive candidate for the development of novel therapeutics. As research in this area continues to advance, the compound is expected to contribute to the discovery of more effective and safer treatments for various diseases.

• 55327-30-5(2-(4-methylphenyl)-1,3-oxazole-4-carbaldehyde)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)